Amylyx’s withdrawn-from-market…
Amylyx’s withdrawn-from-market Relyvrio has failed to make an impact on [...]
Wugen has raised $115 million,…
Wugen has raised $115 million, tapping a Fidelity-led syndicate to [...]
Right on the heels of a similar…
Right on the heels of a similar deal, Fosun Pharma [...]
Akeso and Summit Therapeutics’…
Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has [...]
Eight months after Sanofi’s…
Eight months after Sanofi’s former Chief Medical Officer, Dietmar Berger, [...]
Pfizer is laying off 100 employees…
Pfizer is laying off 100 employees in Bothell, Washington, which [...]
Weeks after telegraphing a series…
Weeks after telegraphing a series of upgrades to its Mexico [...]
Regeneron has reported a phase 3…
Regeneron has reported a phase 3 win in generalized myasthenia [...]
Another cell therapy biotech has…
Another cell therapy biotech has run out of steam, this [...]
Akeso is adding a pair of…
Akeso is adding a pair of late-stage wins to its [...]